TY - JOUR
T1 - Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint
AU - Lutter, Lisanne
AU - van der Wal, M Marlot
AU - Brand, Eelco C
AU - Maschmeyer, Patrick
AU - Vastert, Sebastiaan
AU - Mashreghi, Mir-Farzin
AU - van Loosdregt, Jorg
AU - van Wijk, Femke
N1 - Funding Information:
We thank Sytze de Roock for help with selecting donor samples, Single-Cell Discoveries for running our single-cell RNA-sequencing (SORT-seq), and Pawel Durek for providing us with the single-cell TCR-sequencing data. ECB was supported by the Alexandre Suerman programme for MD and PhD candidates of the University Medical Centre Utrecht, The Netherlands. FW is supported by a VIDI grant from the Netherlands Organisation for Scientific Research (ZonMw, 91714332). ECB and FW are co-applicants on an Investigator Initiated research grant of Pfizer unrelated to this manuscript.
Funding Information:
We thank Sytze de Roock for help with selecting donor samples, Single‐Cell Discoveries for running our single‐cell RNA‐sequencing (SORT‐seq), and Pawel Durek for providing us with the single‐cell TCR‐sequencing data. ECB was supported by the Alexandre Suerman programme for MD and PhD candidates of the University Medical Centre Utrecht, The Netherlands. FW is supported by a VIDI grant from the Netherlands Organisation for Scientific Research (ZonMw, 91714332). ECB and FW are co‐applicants on an Investigator Initiated research grant of Pfizer unrelated to this manuscript.
Publisher Copyright:
© 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.
PY - 2022
Y1 - 2022
N2 - Objective: Tregs are crucial for immune regulation, and environment-driven adaptation of effector (e)Tregs is essential for local functioning. However, the extent of human Treg heterogeneity in inflammatory settings is unclear.Methods: We combined single-cell RNA- and TCR-sequencing on Tregs derived from three to six patients with juvenile idiopathic arthritis (JIA) to investigate the functional heterogeneity of human synovial fluid (SF)-derived Tregs from inflamed joints. Confirmation and suppressive function of the identified Treg clusters was assessed by flow cytometry.Results: Four Treg clusters were identified; incoming, activated eTregs with either a dominant suppressive or cytotoxic profile, and GPR56
+CD161
+CXCL13
+ Tregs. Pseudotime analysis showed differentiation towards either classical eTreg profiles or GPR56
+CD161
+CXCL13
+ Tregs supported by TCR data. Despite its most differentiated phenotype, GPR56
+CD161
+CXCL13
+ Tregs were shown to be suppressive. Furthermore, BATF was identified as an overarching eTreg regulator, with the novel Treg-associated regulon BHLHE40 driving differentiation towards GPR56
+CD161
+CXCL13
+ Tregs, and JAZF1 towards classical eTregs.
Conclusion: Our study reveals a heterogeneous population of Tregs at the site of inflammation in JIA. SF Treg differentiate to a classical eTreg profile with a more dominant suppressive or cytotoxic profile that share a similar TCR repertoire, or towards GPR56
+CD161
+CXCL13
+ Tregs with a more distinct TCR repertoire. Genes characterising GPR56
+CD161
+CXCL13
+ Tregs were also mirrored in other T-cell subsets in both the tumor and the autoimmune setting. Finally, the identified key regulators driving SF Treg adaptation may be interesting targets for autoimmunity or tumor interventions.
AB - Objective: Tregs are crucial for immune regulation, and environment-driven adaptation of effector (e)Tregs is essential for local functioning. However, the extent of human Treg heterogeneity in inflammatory settings is unclear.Methods: We combined single-cell RNA- and TCR-sequencing on Tregs derived from three to six patients with juvenile idiopathic arthritis (JIA) to investigate the functional heterogeneity of human synovial fluid (SF)-derived Tregs from inflamed joints. Confirmation and suppressive function of the identified Treg clusters was assessed by flow cytometry.Results: Four Treg clusters were identified; incoming, activated eTregs with either a dominant suppressive or cytotoxic profile, and GPR56
+CD161
+CXCL13
+ Tregs. Pseudotime analysis showed differentiation towards either classical eTreg profiles or GPR56
+CD161
+CXCL13
+ Tregs supported by TCR data. Despite its most differentiated phenotype, GPR56
+CD161
+CXCL13
+ Tregs were shown to be suppressive. Furthermore, BATF was identified as an overarching eTreg regulator, with the novel Treg-associated regulon BHLHE40 driving differentiation towards GPR56
+CD161
+CXCL13
+ Tregs, and JAZF1 towards classical eTregs.
Conclusion: Our study reveals a heterogeneous population of Tregs at the site of inflammation in JIA. SF Treg differentiate to a classical eTreg profile with a more dominant suppressive or cytotoxic profile that share a similar TCR repertoire, or towards GPR56
+CD161
+CXCL13
+ Tregs with a more distinct TCR repertoire. Genes characterising GPR56
+CD161
+CXCL13
+ Tregs were also mirrored in other T-cell subsets in both the tumor and the autoimmune setting. Finally, the identified key regulators driving SF Treg adaptation may be interesting targets for autoimmunity or tumor interventions.
KW - adaptation
KW - arthritis
KW - inflammatory regulatory T cells
KW - single-cell RNA-sequencing
UR - http://www.scopus.com/inward/record.url?scp=85141200785&partnerID=8YFLogxK
U2 - 10.1002/cti2.1420
DO - 10.1002/cti2.1420
M3 - Article
C2 - 36204213
SN - 2050-0068
VL - 11
JO - Clinical & translational immunology
JF - Clinical & translational immunology
IS - 10
M1 - e1420
ER -